Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-06
2005-09-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S494000
Reexamination Certificate
active
06939890
ABSTRACT:
A class of novel indole is disclosed together with the use of such compounds for inhibiting sPLA2mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.
REFERENCES:
patent: 5420289 (1995-05-01), Musser et al.
patent: 0 620 215 (1994-10-01), None
patent: 0 675 110 (1995-10-01), None
patent: WO 99 21546 (1999-05-01), None
patent: WO 99 21559 (1999-05-01), None
Harper Richard Waltz
Lin Ho-Shen
Richett Michael Enrico
Anderson Rebecca
Eli Lilly and Company
Ginah Francis O.
McKane Joseph K.
LandOfFree
sPLA2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with sPLA2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and sPLA2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3416889